ECLIPSE Ti2-I

In April 2022, insurance coverage for infertility treatment started in Japan, making it easier for couples who want to conceive to receive ICSI treatment. However, in general, there is still a belief that “infertility is not a disease”, so there are many patients who suffer from anxiety or feel impatient during treatment. We interviewed Shoko Ieda and Sumi Shimamura of the Minatomirai Yume Clinic, who say that they find it rewarding to acknowledge these emotions and help such patients with the birth of their babies, about their impressions of using “ECLIPSE Ti2-I”.

*Customers have provided feedback to Nikon on this microscope’s features and clinical usefulness, based on their own personal experience

Tatsuya Kobayashi, Ph.D.
Fujita Health University
Fujita Medical Innovation Center Tokyo
The Center for Advanced Reproductive Medicine
Department of Regulatory Science
Associate Professor

The declining birth rate presents a critical social issue that demands attention. Advancements in assisted reproductive technology (ART) are further anticipated to play a key role in addressing this issue. Fujita Medical Innovation Center Tokyo (FMiC) is committed to clinical practice, and the ongoing research and development of ART to help more people wishing to become parents. Nikon’s motorized inverted microscope for ICSI/IMSI, the ECLIPSE Ti2-I, plays a key role in this process. To gain deeper insights into its implementations and practical applications, we spoke with Dr. Tatsuya Kobayashi, an embryologist and Associate Professor at Fujita Health University’s Department of Regulatory Science.

*This page contains interviews with healthcare professionals regarding our products. However, these interviews do not guarantee the efficacy, effectiveness, or performance of the products, nor do they constitute an official endorsement, recommendation, advice, or selection by the featured professionals.